Your browser doesn't support javascript.
loading
A phase I COVID-19 vaccine trial among SARS-CoV-2 seronegative and seropositive individuals in Uganda utilizing a self-amplifying RNA vaccine platform: Screening and enrollment experiences.
Kitonsa, Jonathan; Kamacooko, Onesmus; Ruzagira, Eugene; Nambaziira, Florence; Abaasa, Andrew; Serwanga, Jennifer; Gombe, Ben; Lunkuse, Jane; Naluyinda, Hadijah; Tukamwesiga, Naboth; Namata, Tamara; Kigozi, Antony; Kafeero, Paddy; Basajja, Vincent; Joseph, Sarah; Pierce, Benjamin F; Shattock, Robin; Kaleebu, Pontiano.
Afiliación
  • Kitonsa J; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Kamacooko O; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Ruzagira E; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Nambaziira F; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Abaasa A; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Serwanga J; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
  • Gombe B; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Lunkuse J; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Naluyinda H; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Tukamwesiga N; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Namata T; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Kigozi A; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Kafeero P; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Basajja V; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Joseph S; Medical Research Council/Uganda Virus Research Institute, London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Pierce BF; Department of Infectious Disease, Imperial College London, London, UK.
  • Shattock R; Department of Infectious Disease, Imperial College London, London, UK.
  • Kaleebu P; Department of Infectious Disease, Imperial College London, London, UK.
Hum Vaccin Immunother ; 19(2): 2240690, 2023 08 01.
Article en En | MEDLINE | ID: mdl-37553178
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Adolescent / Adult / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Uganda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Adolescent / Adult / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Uganda